Anti-HDV immunoglobulin M testing in hepatitis delta revisited: Correlations with disease activity and response to pegylated interferon-α2a treatment

Antiviral Therapy

Volumn 17, Issue 2, 2012, Pages 305-312

  Mederacke, Ingmar ^a   Yurdaydin, Cihan ^b   Dalekos, George N ^c   Bremer, Birgit ^a   Erhardt, Andreas ^d   Cakaloglu, Yilmaz ^e   Yalcin, Kendal ^f   Gurel, Selim ^g   Zeuzem, Stefan ^h   Zachou, Kalliopi ^c   Bozkaya, Hakan ^b   Dienes, Hans Peter ⁱ   Manns, Michael P ^a   Wedemeyer, Heiner ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ANKARA UNIVERSITY   (Turkey)

^c UNIVERSITY OF THESSALY   (Greece)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e MEMORIAL HOSPITAL   (Turkey)

^f DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^g ULUDAG UNIVERSITY   (Turkey)

^h UNIVERSITY HOSPITAL FRANKFURT   (Germany)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN M ANTIBODY; PEGINTERFERON ALPHA2A; PLACEBO; VIRUS DNA; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTICAL EQUIPMENT; ANTIBODY DETECTION; ANTIBODY TITER; ANTIVIRAL THERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD;

ADENINE; ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS ANTIBODIES; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; IMMUNOGLOBULIN M; INTERFERON-ALPHA; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RNA, VIRAL; YOUNG ADULT;

EID: 84860326665     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1926     Document Type: Review

References (25)

1. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010; 7:31-40.
2. Yurdaydin C, Idilman R, Bozkaya H, Bozdayi AM. Natural history and treatment of chronic delta hepatitis. J Viral Hepat 2010; 17:749-756.
3. Mederacke I, Bremer B, Heidrich B, et al. Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. J Clin Microbiol 2010; 48:2022-2029.
4. Le Gal F, Gordien E, Affolabi D, et al. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Microbiol 2005; 43:2363-2369. (Pubitemid 40656252)
5. Dimitrakakis M, Waters MJ, Wootton A, Gust I. Detection of IgM antibodies to delta antigen after coinfection and superinfection with the delta virus. J Med Virol 1986; 20:305-311. (Pubitemid 17221919)
6. Farci P, Gerin JL, Aragona M, et al. Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus. JAMA 1986; 255:1443-1446. (Pubitemid 16167469)
7. Borghesio E, Rosina F, Smedile A, et al. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation. Hepatology 1998; 27:873-876. (Pubitemid 28103568)
8. Sagnelli E, Stroffolini T, Ascione A, et al. Decrease in HDV endemicity in Italy. J Hepatol 1997; 26:20-24. (Pubitemid 27072600)
9. Deǧertekin H, Yalcin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int 2008; 28:494-498. (Pubitemid 351411135)
10. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection - not a vanishing disease in Europe! Hepatology 2007; 45:1331-1332. (Pubitemid 46775802)
11. Cross TJ, Rizzi P, Horner M, et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008; 80:277-282.
12. Gaeta GB, Stroffolini T, Smedile A, Niro G, Mele A. Hepatitis delta in Europe: vanishing or refreshing? Hepatology 2007; 46:1312-1313. (Pubitemid 350144805)
13. Wedemeyer H. Re-emerging interest in hepatitis delta: new insights into the dynamic interplay between HBV and HDV. J Hepatol 2010; 52:627-629.
14. Wedemeyer H, Yurdaydin C, Dalekos GN, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 2011; 364:322-331.
15. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-699.
16. Deterding K, Tegtmeyer B, Cornberg M, et al. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV. J Hepatol 2006; 45:770-778. (Pubitemid 44646680)
17. Takahashi M, Kusakai S, Mizuo H, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection. J Clin Microbiol 2005; 43:49-56. (Pubitemid 40096279)
18. Lindsay KL, Nizze JA, Koretz R, Gitnick G. Diagnostic usefulness of testing for anti-HBc IgM in acute hepatitis B. Hepatology 1986; 6:1325-1328. (Pubitemid 17210562)
19. Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003; 19:225-234. (Pubitemid 37011337)
20. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23:275-306.
21. Wiegand J, Jackel E, Cornberg M, et al. Long-term follow-up after successful interferon therapy of acute hepatitis C. Hepatology 2004; 40:98-107. (Pubitemid 38868928)
22. Platanias LC. Mechanisms of type-I- and type-II-interferonmediated signalling. Nat Rev Immunol 2005; 5:375-386.
23. Grabowski J, Yurdaydin C, Zachou K, et al. Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment. Liv Int 2011; doi: 10.1111/j.1478-3231.2011.02593.x
24. + T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol 1997; 71:2241-2251. (Pubitemid 27078605)
25. Grabowski J, Suneetha PV, Jaroszewicz J, et al. HDV- and HBV-specific T cell response patterns in patients with delta hepatitis. Hepatology 2009; 50:733A-734A.